Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 SAFC Expands API Capacity in Europe | Contract Pharma

What are you searching for?

Sign in
Breaking News

SAFC Expands API Capacity in Europe

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

SAFC is investing $10 million to increase cGMP commercial-scale API manufacturing capacity at its SAFC Pharma, Arklow, Ireland facility, and to expand capacity to enhance manufacturing operations at its Buchs, Switzerland facilities.

The company will invest $4.7 million at the Arklow facility and will increase production capacity and capability. The site will upgrade the pilot plant and add additional vessels to increase chemistry capacity for API products. Additional enhancements are expected to increase utility capacity and further increase the site’s environmental performance. The expansion is scheduled for 1Q2008.

At the Buchs site, the company will invest $5.4 million to extend its existing cGMP production facility with a 17,200-sq.-ft. expansion designed to enhance production capacity by 25% through improved materials flow and separation, and increased materials storage. The new two-level storage facility is expected to become fully operational in spring 2008. The site supports manufacturing operations for the SAFC Pharma and SAFC Supply Solutions business sectors.

SAFC president Frank Wicks commented, “These significant investments enhance our determination to support SAFC Pharma’s rapid growth and help us reduce our environmental footprint, maintaining our position as one of the most responsible companies in the industry. The expansion of the Arklow facility underlines the desire of our customers to have their API manufactured to a reassuringly high quality standard in a superior technical environment, partnered with a premium company that can ensure a security of supply.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics